TIA-1 Positive Tumor-Infiltrating Lymphocytes in Nevi and Melanomas

This publication has 12 references indexed in Scilit:

• Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study
  Melanoma Research, 1998
• Neoplastic progression and prognosis in melanoma
  Seminars in Cutaneous Medicine and Surgery, 1996
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
  Cancer, 1996
• Comparison of two prognostic models predicting survival in patients with malignant melanoma
  Human Pathology, 1995
• The CTL's kiss of death
  Cell, 1995
• Further validation of the prognostic model for stage I malignant melanoma based on tumor progression
  Journal of Cutaneous Pathology, 1993
• A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells
  Cell, 1991
• Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells
  Journal of Surgical Oncology, 1990
• Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
  JNCI Journal of the National Cancer Institute, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988